Skip to main content
Equibles

Advisors Asset Management, Inc.

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1297376 Monument, CO
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,445,598
+$4,058,430 QoQ
Shares Held
17,228
+148.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#107
of 414 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Advisors Asset Management, Inc. holds $39,929,265 across 31 Biotechnology names. LGND ranks #2 (13.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 25,909 $12,869,777
2 LGND
Ligand Pharmaceuticals Inc
This page 		17,228 $5,445,598
3 INCY
Incyte Corp
 24,359 $2,761,336
4 ARQT
Arcutis Biotherapeutics, Inc.
 95,934 $2,515,389
5 ASND
Ascendis Pharma A/S
 9,146 $2,439,421
6 RYTM
Rhythm Pharmaceuticals, Inc.
 21,896 $2,431,112
7 REGN
Regeneron Pharmaceuticals, Inc.
 2,379 $1,483,401
8 PTCT
Ptc Therapeutics, Inc.
 15,280 $1,246,389

All Filings in LGND

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,445,598 17,228
2026-03-31 $1,387,168 6,948
2025-12-31 $630,737 3,336
2025-09-30 $602,807 3,403
2025-06-30 $401,745 3,534
2025-03-31 $298,702 2,841
2024-12-31 $241,301 2,252
2023-09-30 $414,586 6,919
2023-06-30 $508,377 7,051
2023-03-31 $522,276 7,100
2022-12-31 $481,895 7,214
2022-09-30 $648,235 7,528
2022-06-30 $705,640 7,909
2022-03-31 $1,470,919 13,076
2021-12-31 $1,395,545 9,035
2021-09-30 $984,991 7,070
2021-06-30 $940,369 7,168
2021-03-31 $1,097,182 7,197
2020-12-31 $730,161 7,342
2020-09-30 $558,861 5,863
2020-06-30 $434,760 3,887
2020-03-31 $250,956 3,451